Samsara leverages its safety-first approach and 14 trillion data points to expand beyond telematics into comprehensive ...

Insight Molecular Diagnostics (Nasdaq: IMDX) moved its headquarters from Irvine, Calif., to Nashville, Tenn., in June 2025. The company’s new NASDAQ symbol became effective June 18. Investors may ...

As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...

Genomic research holds incredible promise for improving human health, but one major challenge has slowed its progress: ...

The adaptive, biomarker-directed trial allows researchers to enrich for best responders and open new sub-studies for non-responders based on emerging data.

Researchers at Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome ...

As interest in DNA methylation continues to grow across both basic and translational research, there is a pressing need for ...

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.

Over the last 10 years, breakthroughs in understanding the genetic instructions passed from parent to offspring have put researchers closer than ever before to efficiently decoding DNA with 100% ...

Vienna, Austria – June 6, 2025 — Myllia Biotechnology, a pioneer in functional genomics in primary human cells, today announced a major technological breakthrough with the launch of VISTA™—the first ...

Method: Single-cell sequencing technology is a novel high-throughput method that can reveal differences between different cell types and their role in disease. Results: ... The cDNA is then fragmented ...